Literature DB >> 23982363

Revealing the incidentalome when targeting the tumor genome.

Yvonne Bombard1, Mark Robson, Kenneth Offit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23982363      PMCID： PMC4018628          DOI： 10.1001/jama.2013.276573

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making.

Authors:  Lainie Friedman Ross; Mark A Rothstein; Ellen Wright Clayton
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

2.  Whole-genome sequencing: a step closer to personalized medicine.

Authors:  Boris Pasche; Devin Absher
Journal:  JAMA       Date:  2011-04-20       Impact factor: 56.272

3.  Risks to relatives in genomic research: a duty to warn?

Authors:  Yvonne Bombard; Kenneth Offit; Mark E Robson
Journal:  Am J Bioeth       Date:  2012       Impact factor: 11.229

4.  The "duty to warn" a patient's family members about hereditary disease risks.

Authors:  Kenneth Offit; Elizabeth Groeger; Sam Turner; Eve A Wadsworth; Mary A Weiser
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

5.  Citizens' perspectives on personalized medicine: a qualitative public deliberation study.

Authors:  Yvonne Bombard; Julia Abelson; Dorina Simeonov; Francois-Pierre Gauvin
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

6.  Return of secondary genomic findings vs patient autonomy: implications for medical care.

Authors:  Robert Klitzman; Paul S Appelbaum; Wendy Chung
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

Review 7.  Translating genomics in cancer care.

Authors:  Yvonne Bombard; Peter B Bach; Kenneth Offit
Journal:  J Natl Compr Canc Netw       Date:  2013-11       Impact factor: 11.908

8.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

9.  Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies.

Authors:  Katrina A B Goddard; Evelyn P Whitlock; Jonathan S Berg; Marc S Williams; Elizabeth M Webber; Jennifer A Webster; Jennifer S Lin; Kasmintan A Schrader; Doug Campos-Outcalt; Kenneth Offit; Heather Spencer Feigelson; Celine Hollombe
Journal:  Genet Med       Date:  2013-04-04       Impact factor: 8.822
  9 in total
  30 in total

1.  Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned.

Authors:  Bich-Thu Duong; Ravi Savarirayan; Ingrid Winship
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

Review 2.  Getting personal: Head and neck cancer management in the era of genomic medicine.

Authors:  Andrew C Birkeland; Wendy R Uhlmann; J Chad Brenner; Andrew G Shuman
Journal:  Head Neck       Date:  2015-08-13       Impact factor: 3.147

Review 3.  Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.

Authors:  Senthilkumar Damodaran; Michael F Berger; Sameek Roychowdhury
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

4.  Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.

Authors:  D Williams Parsons; Angshumoy Roy; Sharon E Plon; Sameek Roychowdhury; Arul M Chinnaiyan
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

5.  Decade in review--genomics: a decade of discovery in cancer genomics.

Authors:  Kenneth Offit
Journal:  Nat Rev Clin Oncol       Date:  2014-10-07       Impact factor: 66.675

Review 6.  The ins and outs of molecular pathology reporting.

Authors:  Véronique Tack; Kelly Dufraing; Zandra C Deans; Han J van Krieken; Elisabeth M C Dequeker
Journal:  Virchows Arch       Date:  2017-03-26       Impact factor: 4.064

7.  Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.

Authors:  Y Nancy You; Ester Borras; Kyle Chang; Brandee A Price; Maureen Mork; George J Chang; Miguel A Rodriguez-Bigas; Brian K Bednarski; Funda Meric-Bernstam; Eduardo Vilar
Journal:  Dis Colon Rectum       Date:  2019-04       Impact factor: 4.585

8.  Physician Experiences and Understanding of Genomic Sequencing in Oncology.

Authors:  Caroline M Weipert; Kerry A Ryan; Jessica N Everett; Beverly M Yashar; Arul M Chinnaiyan; J Scott Roberts; Raymond De Vries; Brian J Zikmund-Fisher; Victoria M Raymond
Journal:  J Genet Couns       Date:  2017-08-24       Impact factor: 2.537

9.  Traditional roles in a non-traditional setting: genetic counseling in precision oncology.

Authors:  Jessica N Everett; Shanna L Gustafson; Victoria M Raymond
Journal:  J Genet Couns       Date:  2014-03-01       Impact factor: 2.537

10.  Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.

Authors:  Victoria M Raymond; Stacy W Gray; Sameek Roychowdhury; Steve Joffe; Arul M Chinnaiyan; D Williams Parsons; Sharon E Plon
Journal:  J Natl Cancer Inst       Date:  2015-11-20       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.